Evolving Systems Reports First Quarter 2013 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Evolving Systems Reports First Quarter 2013 Financial Results

ENGLEWOOD, CO--(Marketwired - May 7, 2013) - Evolving Systems, Inc. ( NASDAQ : EVOL )

Total revenue of $6.7 million, up 13% year over year

Adjusted EBITDA of $2.0 million, up 144% year over year

Net income of $1.2 million, up 55% year over year

Company generates $2.8 million in cash from operations, up from $1.5 million in Q1 last year

Second quarter dividend declared: $0.08 per share to stockholders of record on June 10, 2013, payable July 12, 2013

Evolving Systems, Inc. ( NASDAQ : EVOL ), a leading provider of strategic solutions to telecom operators worldwide, today reported strong revenue and profit growth for its first quarter ended March 31, 2013.

"We're off to a strong start to 2013. First quarter revenue increased by 13%, led by license and services revenue growth of 19%, and adjusted-EBITDA increased by 144%," said Thad Dupper, Chairman and CEO. "First quarter bookings were in line with our expectations, growing year over year. Our Dynamic SIM Allocation™ (DSA) bookings came in well above our expectations with sequential quarter growth of 93%, led by upgrades from an existing DSA customer. Profitability was particularly noteworthy, with record first quarter gross margins of 72%, adjusted-EBITDA margins of 30% and operating margins of 27%. In addition, we grew cash and cash equivalents to $11.5 million from a year-ending $8.8 million, while continuing to invest in enhancing DSA functionality with the addition of our SIM Reservation Portal. As a result of our solid and sustained profitability, our Board of Directors today declared a second quarter dividend of $0.08 per share as a tangible sign of the confidence we have in our business."

First Quarter Highlights

  • Revenue increased 13% to $6.7 million from $5.9 million in the same quarter last year. License and services revenue grew 19% to $4.5 million from $3.8 million. Customer support revenue was up slightly to $2.2 million from $2.1 million.
  • Operating income increased 210% to $1.8 million from $0.6 million in the first quarter last year.
  • Net income increased 55% to $1.2 million from $0.8 million in the first quarter last year. Diluted net income per share was $0.10, up from $0.07.
  • Adjusted EBITDA of $2.0 million, up 144% from $0.8 million in the same quarter last year.
  • Cash Flow: The Company generated $2.8 million in cash from operations in the first quarter compared with $1.5 million in the same quarter last year.
  • Balance Sheet: Cash and cash equivalents at March 31, 2013, were $11.5 million, up from $8.8 million at 2012 year-end.
  • Dividend Update: The Company declared a second quarter dividend of $0.08 per share to stockholders of record on June 10, 2013, payable July 12, 2013.

Bookings and Backlog Highlights

  • First quarter bookings totaled $5.7 million, up slightly from $5.6 million in the same quarter last year. First quarter bookings included $3.6 million in license and services and $2.1 million in customer support. DSA license and services bookings in the first quarter were $1.8 million, down from $2.6 million year over year. TSA license and services bookings were $1.8 million, up from $1.2 million last year. Bookings are defined as new, non-cancelable orders expected to be recognized as revenue during the following 12 months.
  • Total backlog at March 31, 2013, was $9.8 million compared to $12.5 million a year ago. License and services backlog totaled $5.6 million and was comprised of $3.1 million in DSA and $2.5 million in TSA. Customer support backlog was $4.2 million.

Conference Call The Company will conduct a conference call and webcast today at 2:30 p.m. Mountain Time. The call-in numbers for the conference call are 1-877-303-6316 for domestic toll free and 650-521-5176 for international callers. The conference ID is 57803570. A telephone replay will be available through May 21, 2013, and can be accessed by calling 1-855-859-2056 or 1-404-537-3406. Conference ID 57803570. To access a live webcast of the call, please visit Evolving Systems' website at www.evolving.com . A replay of the Webcast will be accessible at that website through May 21, 2013.

Non-GAAP Financial Measures Evolving Systems reports its financial results in accordance with accounting principles generally accepted in the U.S. (GAAP). In addition, the Company is providing in this news release non-GAAP financial information in the form of net income, diluted net income per share and adjusted EBITDA (earnings before interest, taxes, depreciation, amortization, impairment, stock compensation and gain/loss on foreign exchange transactions.) Management believes these non-GAAP financial measures are useful to investors and lenders in evaluating the overall financial health of the Company in that they allow for greater transparency of additional financial data routinely used by management to evaluate performance. Investors and financial analysts who follow the Company use non-GAAP net income and non-GAAP diluted income per share to compare the Company against other companies. Adjusted EBITDA can be useful for lenders as an indicator of earnings available to service debt. Non-GAAP financial measures should not be considered in isolation from or as an alternative to the financial information prepared in accordance with GAAP.

About Evolving Systems® Evolving Systems, Inc. ( NASDAQ : EVOL ) is a provider of software and services to 50 network operators in over 40 countries worldwide. The Company's product portfolio includes market-leading activation products that address subscriber service activation, SIM card activation, mobile broadband activation as well as the activation of connected devices. Founded in 1985, the Company has headquarters in Englewood, Colorado, with offices in the United Kingdom, India and Malaysia. For more information please visit www.evolving.com or follow us on Twitter: http://twitter.com/EvolvingSystems

CAUTIONARY STATEMENT This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, based on current expectations, estimates and projections that are subject to risk. Specifically, statements about the Company's future orders, the market for the Company's DSA and TSA products, and the Company's continued ability to pay dividends or post quarterly results that are similar to those described in this press release are forward-looking statements. These statements are based on our expectations and are naturally subject to uncertainty and changes in circumstances. Readers should not place undue reliance on these forward-looking statements, and the Company may not undertake to update these statements. Actual results could vary materially from these expectations. For a more extensive discussion of Evolving Systems' business, and important factors that could cause actual results to differ materially from those contained in the forward-looking statements, please refer to the Company's Form 10-K filed with the SEC on March 12, 2013, as well as other SEC filings, including Forms 10-Q, 10-Q/A, 8-K and press releases.

   
   
Consolidated Statements of Operations  
(In thousands except per share data)  
   
(Unaudited)   Three months ended  
    March 31,  
    2013     2012  
Revenue:                
  License fees and services   $ 4,507     $ 3,784  
  Customer support     2,162       2,124  
Total revenue     6,669       5,908  
Costs of revenue and operating expenses:                
  Costs of license fees and services, excluding depreciation and amortization     1,536       1,818  
  Costs of customer support excluding depreciation and amortization     308       360  
  Sales and marketing     1,301       1,341  
  General and administrative     895       913  
  Product development     713       729  
  Depreciation     37       73  
  Amortization     98       99  
Total costs of revenue and operating expenses     4,888       5,333  
  Income (loss) from operations     1,781       575  
Other income (expense):                
  Interest income     3       21  
  Interest income, related party     -       432  
  Interest expense     (6 )     -  
  Foreign currency exchange loss     (43 )     (96 )
Other income (expense), net     (46 )     357  
Income from operations before income taxes     1,735       932  
    Income tax expense     562       174  
Net income   $ 1,173     $ 758  
Basic income per common share   $ 0.10     $ 0.07  
Diluted income per common share   $ 0.10     $ 0.07  
Weighted average basic shares outstanding     11,409       11,164  
Weighted average diluted shares outstanding     11,691       11,369  
                 
                 
                 
Consolidated Balance Sheets  
(In thousands)   March 31,     December 31,  
ASSETS   2013     2012  
Current Assets:                
  Cash and cash equivalents   $ 11,460     $ 8,844  
  Short-term restricted cash     50       53  
  Contract receivables, net     5,345       4,803  
  Unbilled work-in-progress, net     3,600       4,802  
  Prepaid and other current assets     877       1,133  
    Total current assets     21,332       19,635  
Property and equipment, net     193       211  
Amortizable intangible assets, net     96       204  
Goodwill     15,531       16,510  
Long-term deferred income taxes     -       27  
Other long-term assets     4       6  
    Total assets   $ 37,156     $ 36,593  
LIABILITIES AND STOCKHOLDERS' EQUITY                
Current liabilities:                
  Current portion of capital lease obligations   $ 4     $ 4  
  Accounts payable and accrued liabilities     3,228       3,833  
  Income taxes payable     545       308  
  Dividends payable     913       -  
  Unearned revenue     2,354       1,596  
    Total current liabilities     7,044       5,741  
Long-term liabilities:                
  Capital lease obligations, net     14       16  
  Long-term deferred income taxes     39       -  
    Total liabilities     7,097       5,757  
Stockholders' equity:                
  Common stock     11       11  
  Additional paid-in capital     92,068       91,957  
  Treasury stock     (1,253 )     (1,253 )
  Accumulated other comprehensive loss     (4,445 )     (3,297 )
  Accumulated deficit     (56,322 )     (56,582 )
    Total stockholders' equity     30,059       30,836  
  Total liabilities and stockholders' equity   $ 37,156     $ 36,593  
                   
                   
                   
Reconciliation of GAAP to Non-GAAP Financial Measures  
(In thousands except per share data)  
(Unaudited)  
    Three months ended  
    March 31,  
    2013     2012  
Non-GAAP net income and income per share:                
GAAP net income   $ 1,173     $ 758  
Amortization of intangible assets     98       99  
Stock-based compensation expense     75       71  
Income tax adjustment for non-GAAP*     (32 )     (34 )
Non-GAAP net income   $ 1,314     $ 894  
                 
Diluted net income per share                
  GAAP   $ 0.10     $ 0.07  
  Non-GAAP   $ 0.11     $ 0.08  
  Non-GAAP continuing operations   $ 0.11     $ 0.08  
  Shares used to compute diluted EPS     11,691       11,369  
                   
                   
    Three months ended  
    March 31,  
    2013   2012  
Adjusted EBITDA:              
               
Net income   $ 1,173   $ 758  
  Depreciation     37     73  
  Amortization of intangible assets     98     99  
  Stock-based compensation expense     75     71  
  Interest expense and other (benefit), net     46     (357 )
  Income tax expense     562     174  
Adjusted EBITDA   $ 1,991   $ 818  
               

*The estimated income tax for non-GAAP net income is adjusted by the amount of additional expense that the Company would accrue if it used non-GAAP results instead of GAAP results in the calculation of its tax liability, taking into account in which tax jurisdiction each of the above adjustments would be made and the tax rate in that jurisdiction.

Investor Relations Jay Pfeiffer Pfeiffer High Investor Relations, Inc. 303.393.7044 Email Contact Press Relations Sarah Hurp Marketing Manager Evolving Systems +44 1225 478060 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ares Commercial Real Estate Gears Up for Q3 Earnings

Updated Category News Views 21

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

Continue Reading
HumanView Relaunch: LEAP Group Decodes Customer Signals

Updated Category News Views 52

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 180

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading

Top 5 Most Recently Viewed Articles

Columbus McKinnon Completes Significant Notes Offering for Growth

Updated Category News Views 97

Columbus McKinnon Completes Important Notes Offering Columbus McKinnon Corporation (NASDAQ: CMCO), a prominent designer and manufacturer in the intelligent motion solutions sector, has successfully completed a notable offering of senior secured notes. This offering totaled $900 million with a set interest rate of 7.125%, maturing in 2033, aimed at supporting the company's...

Continue Reading
Navigating TransMedics Gr's Upcoming Earnings Like a Pro

Updated Category News Views 195

Rollin' into Earnings: What to Expect from TMDX Every now and then, a company catches wind in its sails, and TransMedics Gr (NASDAQ:TMDX)—well, it’s been riding a decent wave lately. With earnings about to drop on February 24, 2026, folks are buzzing, holding their breath, and looking for that golden info nugget to drop. Analysts are pinning their hopes on an earnings...

Continue Reading
Rigel Pharmaceuticals Set to Showcase Innovations at J.P. Morgan

Updated Category News Views 108

Rigel Pharmaceuticals Gears Up for J.P. Morgan Healthcare Conference Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a prominent name in biotechnology focused on hematologic disorders and cancer treatments, is poised to make a significant impact at the upcoming J.P. Morgan Healthcare Conference. The event is set to bring together industry leaders and innovators, making it an...

Continue Reading
Big Lots Introduces Festive Shopping Event Amid Holiday Cheers

Updated Category News Views 293

Exciting Updates from Big Lots This Holiday Season Big Lots is gearing up for the holiday season with some thrilling news for all shoppers. The launch of their new Holiday Shop is set to delight customers, combined with an unforgettable one-day shopping event called ‘Falloweenmas’ which offers great savings and unique decorations for this festive time of year....

Continue Reading
Amcor Welcomes Stephen Scherger as New CFO Amid Changes

Updated Category News Views 273

Amcor Announces New Leadership with Stephen R. Scherger Amcor, a global frontrunner in packaging solutions, has appointed Stephen R. Scherger as its new Executive Vice President and Chief Financial Officer, effective November 10, 2025. This decision comes as the current CFO, Michael Casamento, steps down after dedicating a decade to the company. He will continue in an...

Continue Reading